Correction: J Exp Clin Cancer Res 43, 51 (2024)
10.1186/s13046-024-02974-4
Following publication of the original article [1], Baoyuan Zhang, Ning Li, Jiaming Gao were not captured as co-first authors and equal contributors. This was not declared in the accepted manuscript and the authors failed to correct this during proofing.
The correction does not affect the overall result or conclusion of the article. The original article has been corrected.
Footnotes
The online version of the original article can be found at 10.1186/s13046-024-02974-4.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Baoyuan Zhang, Ning Li, Jiaming Gao are co-first authors and contributed equally to this work.
Contributor Information
Dongmei Ji, Email: jid09@fudan.edu.cn.
Lingying Wu, Email: wulingying@csco.org.cn.
Ruibao Ren, Email: rbren@sjtu.edu.cn.
References
- 1.Zhang B, Li N, Gao J, et al. Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade. J Exp Clin Cancer Res. 2024;43:51. doi: 10.1186/s13046-024-02974-4. [DOI] [PMC free article] [PubMed] [Google Scholar]